Current Ratio in % of Inhibikase Therapeutics, Inc. from Q2 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Inhibikase Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2023 to Q3 2025.
  • Inhibikase Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2025 was 1.3K %, a 458% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)

Inhibikase Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1.3K +1.06K +458% Sep 30, 2025
Q2 2025 1.1K +736 +203% Jun 30, 2025
Q1 2025 983 +492 +100% Mar 31, 2025
Q4 2024 736 +33.3 +4.74% Dec 31, 2024
Q3 2024 232 -541 -70% Sep 30, 2024
Q2 2024 362 -466 -56.3% Jun 30, 2024
Q1 2024 491 Mar 31, 2024
Q4 2023 703 Dec 31, 2023
Q3 2023 773 Sep 30, 2023
Q2 2023 829 Jun 30, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.